EUVIMEDEUVIMED entdecken
Crossref

Secondary metabolites from Etlingera rubroloba rhizome: Profiling, isolation, structural elucidation, and evaluation of biological activities

Sahidin Sahidin, Adryan Fristiohady, Muzuni Muzuni, Sitti Wirdhana Ahmad, Agung Wibawa Mahatva Yodha, Arfan Arfan, Dzaky Aulia Rahman, Wahyuni Wahyuni, Irmanida Batubara, Harlinda Kuspradini, Femi Earnestly, Andini Sundowo

Journal of Applied Pharmaceutical Science · 2026-04 · 16 (4) · 233-244

DOI: 10.7324/japs.2026.273356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Pharmaceutical Science, online erschienen am 01.04.2026. Verfasst von Sahidin Sahidin und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Etlingera rubroloba is a traditional medicinal plant in Southeast Sulawesi, Indonesia. To date, no studies have been reported on the chemical and pharmacological aspects of E. rubroloba rhizomes. The total secondary metabolites of the methanol extract of E. rubroloba rhizome was analysed, by using the UPLC-High-Resolution Mass Spectrometry (HRMS) technique. It involves the isolation and structural elucidation of major compounds through chromatographic and spectroscopic methods, as well as an evaluation of the biological activities of the extracts and compounds, including antioxidant, anti-inflammatory, and antidepressant effects (the latter tested in silico). Six major compounds were identified for the first time from this species: Stigmasterol (ER1), Stigmast-4-en-6β-ol-3-one (ER2), Yakuchinone A (ER3), 1-(3’-methoxy-4’-hydroxyphenyl)-7-(4’’-hydroxyphenyl)-3-heptanone (ER4), 3,5-dimethoxy-4-acetoxy cinnamic alcohol (ER5), and p-Coumaric acid (ER6). The diarylheptanoids (ER3 and ER4) exhibited superior antioxidant activity, while the steroids (ER1 and ER2) demonstrated strong anti-inflammatory effects. Additionally, docking simulations suggested that ER1 and ER2 exhibited low binding energies towards monoamine oxidase, dopamine transporter, and serotonin transporter, indicating a possible relevance to neurotransmission pathways associated with depression. These findings highlight the chemical composition and pharmacological potential of E. rubroloba rhizomes, marking the first report of their antioxidant, anti-inflammatory, as well as their potential to interact with targets associated with depression, which represents a promising avenue for further confirmation through in vitro studies.

Zitieren

APA

Sahidin, S., Fristiohady, A., Muzuni, M., Ahmad, S. W., Yodha, A. W. M., Arfan, A., Rahman, D. A., Wahyuni, W., Batubara, I., Kuspradini, H., Earnestly, F., & Sundowo, A. (2026). Secondary metabolites from Etlingera rubroloba rhizome: Profiling, isolation, structural elucidation, and evaluation of biological activities. Journal of Applied Pharmaceutical Science, 16(4), 233-244. https://doi.org/10.7324/japs.2026.273356

Vancouver

Sahidin S, Fristiohady A, Muzuni M, Ahmad SW, Yodha AWM, Arfan A, et al. Secondary metabolites from Etlingera rubroloba rhizome: Profiling, isolation, structural elucidation, and evaluation of biological activities. Journal of Applied Pharmaceutical Science. 2026;16(4):233-244. doi:10.7324/japs.2026.273356

BibTeX
@article{Sahidin2026,
  author = {Sahidin, Sahidin and Fristiohady, Adryan and Muzuni, Muzuni and Ahmad, Sitti Wirdhana and Yodha, Agung Wibawa Mahatva and Arfan, Arfan and Rahman, Dzaky Aulia and Wahyuni, Wahyuni and Batubara, Irmanida and Kuspradini, Harlinda and Earnestly, Femi and Sundowo, Andini},
  title = {Secondary metabolites from Etlingera rubroloba rhizome: Profiling, isolation, structural elucidation, and evaluation of biological activities},
  journal = {Journal of Applied Pharmaceutical Science},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {233--244},
  doi = {10.7324/japs.2026.273356}
}
Kostenlos starten →